GPR39 and Esophageal Cancer
Author Information
Author(s): Xie Fajun, Liu Haibo, Zhu Ying-Hui, Qin Yan-Ru, Dai Yongdong, Zeng Tingting, Chen Leilei, Nie Changjun, Tang Hong, Li Yan, Fu Li, Guan Xin-Yuan
Primary Institution: State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-Sen University
Hypothesis
The study investigates the role of GPR39 in the development of human esophageal squamous cell carcinoma (ESCC).
Conclusion
GPR39 plays an important tumorigenic role in the development and progression of ESCC.
Supporting Evidence
- GPR39 was overexpressed in 54% of primary ESCC tumors.
- GPR39 overexpression was significantly associated with lymph node metastasis.
- Functional studies showed that GPR39 promotes cell proliferation and tumor formation.
Takeaway
GPR39 is a protein that helps cancer cells grow and spread in esophageal cancer.
Methodology
The study used RT-PCR, immunohistochemistry, and in vitro and in vivo assays to analyze GPR39 expression and its effects on ESCC.
Participant Demographics
The study involved 300 primary ESCC cases and 50 primary ESCC tumors.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website